Cervical Adenosquamous Carcinoma Clinical Trials

39 clinical trials for Cervical Adenosquamous Carcinoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer — RECRUITING · PHASE1
• AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors — RECRUITING · PHASE1
• Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda — RECRUITING · PHASE2
• Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer — ACTIVE_NOT_RECRUITING · NA
• Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers — ACTIVE_NOT_RECRUITING · PHASE3
• Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer — COMPLETED · PHASE1
• Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer — ACTIVE_NOT_RECRUITING
• RT for Adenocarcinoma/Adenosquamous Carcinoma — ACTIVE_NOT_RECRUITING · PHASE1
• Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery — COMPLETED · PHASE3
• Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers — COMPLETED · PHASE1
• Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer — OTHER · NA
• MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer — TERMINATED
• Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer — COMPLETED · PHASE2
• Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer — COMPLETED · PHASE3
• Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women — WITHDRAWN · PHASE2
• Hybrid PET/MR in the Therapy of Cervical Cancer — COMPLETED
• Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer — COMPLETED · PHASE2
• Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer — COMPLETED · PHASE1
• Ixabepilone to Treat Cervical Cancer — TERMINATED · PHASE2
• Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer — COMPLETED · PHASE2
• Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer — COMPLETED · PHASE3
• Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer — COMPLETED · PHASE1
• Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer — COMPLETED · PHASE2
• Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer — OTHER · PHASE1
• ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer — COMPLETED · PHASE2
• Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix — COMPLETED · PHASE3
• Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer — COMPLETED · PHASE2
• Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer — TERMINATED · NA
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes — COMPLETED
• Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer — COMPLETED · PHASE2
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia — COMPLETED · PHASE3
• Collecting Tumor Samples From Patients With Gynecological Tumors — COMPLETED
• Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer — COMPLETED · PHASE2
• Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery — COMPLETED · PHASE2
• Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer — COMPLETED · PHASE2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer — COMPLETED · PHASE1
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer — COMPLETED · PHASE1

Refine this search